Foster City, CA, United States of America

Mikail Hakan Gezginci


Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2005-2009

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Mikail Hakan Gezginci – A Pioneer in Pharmaceutical Advances

Introduction

Mikail Hakan Gezginci, based in Foster City, California, is a notable inventor with a growing portfolio of innovative patents. With three patents to his name, he is recognized for his contributions to the field of pharmaceuticals, particularly in combating viral infections and antimicrobial activities.

Latest Patents

Gezginci's latest patents demonstrate his commitment to addressing significant health challenges. The first patent focuses on "Bicyclic heteroaryl derivatives," which discloses compounds, compositions, and methods for treating infections caused by the Flaviviridae family of viruses. His second patent involves "Aromatic compounds possessing antifungal or antibacterial activity," which provides novel compounds with antibacterial and antifungal properties. This invention includes pharmaceutical compositions that harness these compounds for effective treatments.

Career Highlights

Currently, Mikail Hakan Gezginci is employed at Genelabs Technologies, Inc., where he applies his expertise to advance pharmaceutical research and development. His work is instrumental in driving innovations that can lead to new therapeutic solutions for various health issues.

Collaborations

Throughout his career, Gezginci has collaborated with esteemed colleagues, including Christopher Don Roberts and Janos Botyanszki. These partnerships have contributed to the successful development of his patents and the advancement of their scientific endeavors.

Conclusion

Mikail Hakan Gezginci stands out as a dedicated inventor whose work has the potential to make a lasting impact on public health. His innovative patents reflect a deep understanding of pharmaceutical chemistry, and his ongoing contributions at Genelabs Technologies, Inc. highlight his commitment to addressing crucial medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…